- Forums
- ASX - By Stock
- TRI
- Ann: Positive Results from Phase 2 SAMDE Study
Ann: Positive Results from Phase 2 SAMDE Study, page-13
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TRI (ASX) to my watchlist
|
|||||
Last
2.2¢ |
Change
-0.001(4.35%) |
Mkt cap ! $9.140M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.0¢ | $30.24K | 1.430M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 628760 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 19232 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 40962 | 0.021 |
5 | 628760 | 0.020 |
2 | 725000 | 0.019 |
3 | 1540000 | 0.018 |
1 | 500000 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 238095 | 1 |
0.023 | 343881 | 3 |
0.025 | 158409 | 2 |
0.026 | 712182 | 6 |
0.028 | 160000 | 1 |
Last trade - 14.04pm 13/08/2024 (20 minute delay) ? |
Featured News
TRI (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online